Skip to content

Acute Health Effects Due to Ultrafine Particles From Candles and Cooking

THE ULTRAFINE PROJECT - A Study of Acute Health Effects of Exposure to Particles Generated by Candles and Cooking

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04315740
Acronym
Ultrafine
Enrollment
36
Registered
2020-03-19
Start date
2019-04-01
Completion date
2019-12-20
Last updated
2020-11-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Candle Burning, Cooking, Lung Function Decreased, DNA Damage, Subjective Health, Asthma

Keywords

Particle contamination, Indoor air, Acute health effects, RCT, Asthma

Brief summary

People spend up to 90% of their life indoor, and the way we live and behave in our homes has substantial effects on our health and well-being. Particle contamination is suggested to have substantial negative effects on health, with candles and cooking emitting the largest amount of particles, thus being the largest contributors to indoor air pollution. The overall aim of the present project is to contribute to increased understanding of the association between indoor particulate air pollution and health and well-being.

Detailed description

Introduction: People spend up to 90% of their life indoor, and the way we live and behave in our homes has substantial effects on our health and well-being. Particle contamination is suggested to have substantial negative effects on health, with candles and cooking emitting the largest amount of particles, thus being the largest contributors to indoor air pollution. Little is known about the potential adverse health effects of candles and cooking, and people with asthma may be more susceptible. Aim: To investigate local and systemic effects of short-term exposure to lit candles and cooking among young asthmatics. Design: In a randomised double-blinded cross-over study non-smoking asthmatics (18-25 years) were exposed for five hours at three different exposure conditions separated by 14 days; A) clean filtered air, B) lit candles and C) cooking emissions under controlled environmental conditions. Measurements: TSI P-TRAK Ultrafine Particle Counter was used for particle counts. Health effects, including lung function (FEV1/FVC) and fraction of exhaled nitric oxide (FeNO) were evaluated in relation to local and systemic effects prior to, right after and 24 h. after exposure. Analysis: Mixed methods approach taking both time and exposure into account.

Interventions

OTHERParticles from candles

Generating fine and ultrafine particles from lit candles

OTHERParticles from cooking

Generating fine and ultrafine particles from frying pork in an oven

Nothing but clean air

Sponsors

University of Copenhagen
CollaboratorOTHER
Aarhus University Hospital
CollaboratorOTHER
University of Aarhus
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Masking description

The exposure was generated in small adjacent chamber and thereby led into the exposure chamber using a pipe connection and a small negative pressure. Thus, the exposure could not be observed.

Intervention model description

A randomised double-blinded crossover study

Eligibility

Sex/Gender
ALL
Age
15 Years to 25 Years
Healthy volunteers
Yes

Inclusion criteria

* Aged 15-25 * Medically treated / physician diagnosed mild seasonal asthma * Never smoker or ex-smoker ≥ 6 months * Allergy \> 1 common allergy

Exclusion criteria

* Any other disease that could influence the study parameters * Conditions that prevent safe access to the climate chambers (such as claustrophobia) * Perennial asthma * Need for continuous medical treatment for asthma * Pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Change in Particles in Exhaled Air (Surfactant Protein A & Albumin)Time Frame: At baseline (0 hour), after exposure (5 hours), and the day after exposure (24 hours)PExA: Subjects performed repeated breath maneuvers allowing for airway closure and re-opening, and exhaled particles were optically counted and collected on a membrane using the (novel) PExA® instrument set-up.

Secondary

MeasureTime frameDescription
Change in Fractional exhaled nitric oxide (FENO)At baseline (0 hour), after exposure (5 hours), and the day after exposure (24 hours)NIOX VERO system; Aerocrine AB, Sweden
Change in Blood samplesAt baseline (0 hour), after exposure (5 hours), and the day after exposure (24 hours)Cytokines (IL-8), DNA-damages
Change in Lung Function (FEV1 & FVC)At baseline (0 hour), after exposure (5 hours), and the day after exposure (24 hours)Spirometry
Change in biomarkers in Saliva SampleAt baseline (0 hour), after exposure (5 hours), and the day after exposure (24 hours)An oral svap from Salivette was placed in the mouth of the participant to collect saliva by gently chewing the swab for one minute. Afterwards the saturated swab was removed to the suspended insert and closed firmly with a lid. Then the sample was transferred to a freezer and stored for -80 C until further analysis. The sample will be analyzed for biomarkers (amylase, cortisol, substance P, lysozyme and secretory IgA.)
Change in Subjective SymptomsEvery 30 minute during 5 hours of exposureIn the exposure chamber participants were asked to fill out a symptom questionnaire every 30 minute regarding their well-being and experienced symptoms in eyes, nose and throat. The participants were asked to score their evaluation (rate the strength) of symptoms by placing a cross on a 130 mm open Visual Analogue Scale (VAS). The intensity of any discomfort was registered as the length in mm from the left of the scale to the marker. The scores were rated from 0 to 100% with highest number corresponding to highest discomfort. Health effects were evaluated in relation to rated changes in symptoms.
Change in nasal volume (using Acoustic rhinometry)At baseline (0 hour), after exposure (5 hours), and the day after exposure (24 hours)Is used to assess the nasal cross sectional area and volume. The left and right nasal cavity were studied alternatively until three reproducible measurements were obtained. The minimum cross sectional cavity area was calculated from the means of the measurements. By integration of the area-distance curve, the sum of the volume 2 to 4 (vol2-4) from the nostril was determined on both sides.

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026